Colorectal Cancer Diagnosed Too Late in Youth

Study finds that 80 percent of patients aged 21 or younger had advanced disease at diagnosis, highlighting the importance of recognizing warning signs

November 4, 2026
2 min

The Pathologist

At a Glance

Category	Detail
Condition	Clinical topic addressed by the source article: Colorectal Cancer Diagnosed Too Late in Youth
Key Mechanisms	Mechanisms or clinical associations described in the source article.
Target Population	Patients or participants described in the source article.
Care Setting	Retrospective review of medical records from 84 patients across 34 institutions.

Key Highlights

In this study of 84 patients diagnosed from 2012 to 2023, 80% had stage III or IV disease at diagnosis.
Common symptoms included abdominal or back pain (74%), changes in bowel habits (45%), weight loss (43%), and rectal bleeding (38%).
Median symptom duration before diagnosis was 12 weeks, and median time to colonoscopy was 13 weeks.
Disease recurred in 37% of patients, typically within 11 months; 45% died from colorectal cancer during the study period.
Only 20% reported a first- or second-degree relative with colorectal cancer.

Guideline-Based Recommendations

Diagnosis

The article emphasizes investigating persistent gastrointestinal symptoms in younger patients, including those without a known hereditary predisposition.
The article reports that many tumors had poor differentiation, signet ring features, or mucinous features.
Among patients who underwent germline testing, variants involving mismatch repair genes, TP53, and APC were identified; the article notes the potential role of genetic evaluation.

Management

The article highlights the need for coordinated pediatric and adult oncology care.

Monitoring & Follow-up

Recurrence occurred in 37% of patients, typically within 11 months; the study did not specify a monitoring schedule.

Risks

Recurrence was associated with lymph node involvement, poor tumor differentiation, and signet ring features.
The retrospective study cannot establish whether colorectal cancer incidence is increasing or determine the causes of delayed diagnosis.

Patient & Prescribing Data

Eighty-four patients aged 21 years or younger diagnosed across 34 institutions from 2012 to 2023; patients with previously diagnosed hereditary cancer predisposition syndromes or inflammatory bowel disease were excluded.

The article provides no prescribing or treatment-regimen data. During the study period, 45% of patients died from colorectal cancer.

Clinical Best Practices

The article emphasizes investigating persistent gastrointestinal symptoms in younger patients, even without a known hereditary predisposition.
The article highlights histopathological assessment of tumor features associated with recurrence.
The article highlights the need for coordinated pediatric and adult oncology care.